Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Mitochondrial function in macrophages controls cardiac repair after myocardial infarction
David Weissman, Christoph Maack
David Weissman, Christoph Maack
Published February 15, 2023
Citation Information: J Clin Invest. 2023;133(4):e167079. https://doi.org/10.1172/JCI167079.
View: Text | PDF
Commentary Article has an altmetric score of 27

Mitochondrial function in macrophages controls cardiac repair after myocardial infarction

  • Text
  • PDF
Abstract

Cardiac healing following acute myocardial infarction (MI) involves the mobilization and activation of immune cells, including macrophages. In the early phase after MI, macrophages adopt a proinflammatory phenotype, while polarizing toward a reparative one in the late stage. Although metabolic reprogramming has been observed during this transition, the mechanistic links to macrophage differentiation are still poorly understood. In this issue of the JCI, Cai, Zhao and colleagues demonstrate that mitochondrial function in macrophages governed the resolution of inflammation and tissue repair by modulating the phagocytic removal of apoptotic cells (so-called efferocytosis) as well as myofibroblast activation. These findings provide important mechanistic insights into the potential relevance of metabolic modulation of macrophage functions following MI, which might lead to alternative therapeutic strategies for MI.

Authors

David Weissman, Christoph Maack

×

Figure 1

Myeloid-specific deletion of the mitochondrial complex I protein Ndufs4 compromises macrophage function during cardiac repair after MI.

Options: View larger image (or click on image) Download as PowerPoint
Myeloid-specific deletion of the mitochondrial complex I protein Ndufs4 ...
Following acute MI, immune cells, including monocyte-derived macrophages, remove cell debris through efferocytosis but can also amplify the inflammatory response by secreting proinflammatory mediators. Subsequently, proinflammatory macrophages transition from a proinflammatory to a reparative phenotype, a process that associates with metabolic remodeling: shifting from relying on glycolysis (associated with the proinflammatory phenotype) toward mitochondrial OXPHOS (associated with the reparative phenotype). This transition is characterized by increased secretion of antiinflammatory cytokines, chemokines, and repair factors that stimulate the activation and proliferation of cardiac myofibroblasts, which promote tissue repair and scar formation. In this issue of the JCI, Cai, Zhao, and co-authors (20) report that mitochondrial dysfunction in macrophages, induced by Ndufs4 deletion, can cause excessive mitochondrial ROS production, which primes the cells to a greater inflammatory response while impairing efferocytosis. This process, in turn, blunts macrophage polarization, reducing the reparative phenotype, and suppresses the proliferation and activation of myofibroblasts, resulting in poor wound healing and increased mortality. Interestingly, mitochondria-targeted ROS scavenging improved efferocytosis and myofibroblast functions, resulting in reduced infarct rupture and mortality.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 48 X users
On 1 Facebook pages
21 readers on Mendeley
See more details